back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-07 14:56 Tx date 2024-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$593,082
+15,542 vol $38.16 each |
110,661 | |
| Filed 2023-10-30 18:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,646
+15,800 vol $1.37 each |
110,900 | |
| Filed 2023-10-30 18:03 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$546.00
+400 vol $1.36 each |
95,100 | |
| Filed 2023-10-30 18:03 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,768
+13,800 vol $1.36 each |
94,700 | |
| Filed 2023-10-30 18:02 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-242,700 vol |
80,900 | |
| Filed 2023-10-30 10:05 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,646
+15,800 vol $1.37 each |
353,600 | |
| Filed 2023-10-30 10:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$546.00
+400 vol $1.36 each |
337,800 | |
| Filed 2023-10-30 10:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,768
+13,800 vol $1.36 each |
337,400 | |
| Filed 2023-08-24 16:45 Tx date 2023-08-24 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-967,500
-25,000 vol $38.70 each |
25,000 | |
| Filed 2023-06-05 13:24 Tx date 2023-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$719,786
+18,475 vol $38.96 each |
95,119 | |
| Filed 2023-03-02 16:00 Tx date 2023-02-28 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,043
+21,739 vol $1.29 each |
105,913 | |
| Filed 2022-10-24 09:44 Tx date 2022-10-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+50,000 vol |
323,600 | |
| Filed 2022-10-24 09:42 Tx date 2022-10-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-13,000
-50,000 vol $0.26 each |
84,174 | |
| Filed 2022-06-29 18:58 Tx date 2022-06-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$541,980
+18,000 vol $30.11 each |
76,644 | |
| Filed 2021-12-02 17:30 Tx date 2021-12-01 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,655
+14,170 vol $4.21 each |
134,174 | |
| Filed 2021-06-03 21:57 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$185,600
+10,000 vol $18.56 each |
58,644 | |
| Filed 2021-03-02 21:18 Tx date 2021-02-26 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,103
+13,258 vol $3.93 each |
120,004 | |
| Filed 2020-06-02 20:05 Tx date 2020-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$131,100
+10,000 vol $13.11 each |
48,644 | |
| Filed 2020-04-27 17:53 Tx date 2020-04-24 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,125
+7,500 vol $3.75 each |
273,600 | |
| Filed 2020-04-27 17:52 Tx date 2020-04-24 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,492
+400 vol $3.73 each |
266,100 | |
| Filed 2020-04-24 12:26 Tx date 2020-04-21 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,150
+14,900 vol $3.50 each |
265,700 | |
| Filed 2020-04-24 12:25 Tx date 2020-04-21 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,564
+3,600 vol $3.49 each |
250,800 | |
| Filed 2020-04-24 12:25 Tx date 2020-04-21 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,656
+4,800 vol $3.47 each |
247,200 | |
| Filed 2020-04-24 12:24 Tx date 2020-04-21 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,865
+1,700 vol $3.45 each |
242,400 | |
| Filed 2020-04-24 12:24 Tx date 2020-04-21 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$684.00
+200 vol $3.42 each |
240,700 | |
| Filed 2020-04-24 12:24 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,600
+10,000 vol $3.56 each |
240,500 | |
| Filed 2020-04-24 12:23 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,005
+300 vol $3.35 each |
230,500 | |
| Filed 2020-04-24 12:22 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$635.00
+200 vol $3.17 each |
230,200 | |
| Filed 2020-04-24 12:21 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,726
+8,900 vol $3.34 each |
230,000 | |
| Filed 2020-04-24 12:21 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,308
+7,600 vol $3.33 each |
221,100 | |
| Filed 2020-04-24 12:20 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,637
+3,500 vol $3.33 each |
213,500 | |
| Filed 2020-04-24 12:19 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,628
+2,900 vol $3.32 each |
210,000 | |
| Filed 2020-04-24 12:19 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$331.50
+100 vol $3.31 each |
207,100 | |
| Filed 2020-04-24 12:18 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,720
+4,000 vol $3.18 each |
207,000 | |
| Filed 2020-04-24 12:18 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$632.00
+200 vol $3.16 each |
203,000 | |
| Filed 2020-04-24 12:17 Tx date 2020-04-20 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,764
+2,800 vol $3.13 each |
202,800 | |
| Filed 2020-02-26 10:17 Tx date 2020-02-26 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,132
+10,600 vol $3.22 each |
106,746 | |
| Filed 2019-09-19 14:17 Tx date 2019-09-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,600
+15,000 vol $9.44 each |
38,644 | |
| Filed 2019-02-26 Tx date 2019-02-26 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,964
+8,900 vol $8.76 each |
96,146 | |
| Filed 2018-08-02 Tx date 2013-04-10 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-02 Tx date 2018-08-01 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$8,247
+855 vol $9.65 each |
855 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+15,000 vol $6.20 each |
23,644 | |
| Filed 2018-04-07 Tx date 2018-04-06 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,246 vol |
87,246 | |
| Filed 2017-08-15 Tx date 2017-08-14 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$140,770
+50,000 vol $2.82 each |
50,000 | |
| Filed 2017-08-15 Tx date 2016-09-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-02 Tx date 2017-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,475
+3,500 vol $3.85 each |
8,644 | |
| Filed 2017-05-17 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
80,000 | |
| Filed 2016-12-05 Tx date 2016-12-05 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$341,000
+110,000 vol $3.10 each |
200,000 | |
| Filed 2016-09-27 Tx date 2016-09-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-27 Tx date 2016-09-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,144 vol |
5,144 | |
| Filed 2016-07-13 Tx date 2016-07-12 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,750
+15,000 vol $2.45 each |
65,000 | |
| Filed 2015-05-06 Tx date 2015-05-05 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+5,000 vol $1.26 each |
90,000 | |
| Filed 2014-01-24 Tx date 2014-01-23 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+11,000 vol $0.48 each |
85,000 | |
| Filed 2014-01-24 Tx date 2014-01-23 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$475.00
+1,000 vol $0.475 each |
74,000 |